Selim M. Arcasoy, MD, MPH

Specialties:
Critical Care Medicine, Internal Medicine, Pediatric Pulmonology, Pulmonary Disease, Pulmonology
More specialties
Accepting New Patients
Treats Children
Virtual Visits/Telehealth
Profile Headshot

Overview

selim_arcasoy_md

Dr. Arcasoy was recruited to Columbia University as the Medical Program Director of Lung Transplantation in 2001 from the University of Pennsylvania. After his recruitment, he completely turned around the Lung Transplantation Program to rank amongst the top 5 to 10 programs in the country with regard to volume and patient survival.  Under his leadership, the Lung Transplant Program has been performing more than 80 transplants annually.  In October 2019, Dr. Arcasoy and his team celebrated their 1000th lung transplant since 2001.  Despite high transplant volumes and very sick pretransplant candidates, the survival of lung transplant recipients has remained stellar.  Currently, 1-year survival of lung transplant recipients at Columbia University is 90%, 5-year survival 65%, and 10-year survival 42%. 

Dr. Arcasoy has gained national and international reputation with various leadership roles in professional organizations and scientific societies.  He previously chaired the Thoracic Organ Transplant Committee of the AST and the Transplant Network Steering Committee of the ACCP.  He recently served in the Thoracic Organ Transplant Committee of the OPTN to develop Continuous Distribution of Lungs. He is currently the Associate Chair for Advanced Lung Failure and Transplantation in the Standards and Guidelines Committee of the ISHLT.

Areas of Expertise / Conditions Treated

  • Chronic Lung Disease
  • Chronic Obstruct Pulm Disease/COPD
  • Emphysema
  • General Pulmonology
  • Hypersensitivity Pneumonitis
  • Idiopathic Pulmonary Fibrosis
  • Lung Transplant
  • Pulmonary Critical Care Medicine
  • Pulmonary Disease
  • Pulmonary Fibrosis
  • Pulmonary Medicine
  • Respiratory Failure
  • Restrictive Lung Diseases
  • Transplant Pulmonology

Academic Appointments

  • Dickinson W. Richards, Jr. Professor of Medicine (in Pediatrics) at CUMC

Administrative Titles

  • Medical Program Director, Lung Transplant Program

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Morgan Stanley Children's Hospital

Languages

  • Turkish

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

622 West 168th Street
Floor 14
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, Ege University Medical School, Turkey
  • MPH, Columbia University Mailman School of Public Health
  • Internship: 1993 State University of New York Health Science Center at Brooklyn
  • Residency: 1994 State University of New York Health Science Center at Brooklyn
  • Fellowship: 1997 The University of Pittsburgh Medical Center

Board Certifications

  • Critical Care Medicine
  • Internal Medicine
  • Pulmonary Disease

Honors & Awards

  • 2016: Fellow of the American Society of Transplantation (F.A.S.T.)
  • 2002-21: Inclusion in America’s Top Doctors and Top Doctors: New York Metro Area
  • 2009-21: Inclusion in New York City Super Doctors, New York Times Magazine
  • 2002: Fellow of the American College of Physicians (F.A.C.P.)
  • 2001: Fellow of the American College of Chest Physicians (F.C.C.P.)
  • 1999: Rank Valedictorian of class in Ege University School of Medicine
  • 1984: Rank Valedictorian of class in Tarsus American College
America's Top Doctor
NY Top Doctor

Research

Advanced lung disease and lung transplantation

Research Interests

  • Co-morbidities in advanced pulmonary disease
  • Collaborative investigation in immune tolerance
  • Idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis
  • Lung volume reduction for emphysema
  • Novel immunosuppressive regimens and antimicrobial therapies in lung transplantation
  • Outcomes of patients with advanced lung disease before and after transplantation
  • Patient selection and outcomes on the waiting list for lung transplantation
  • Post-transplant complications
  • Predictors and diagnosis of acute and chronic lung rejection
  • Pulmonary embolism and thrombolytic therapy
  • Studies of genetic testing for diagnosis of organ rejection

Grants

Principal investigator: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow Device plus Standard of Care versus Standard of Care Alone in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post-Single Lung Transplantation. Protocol No: BT-LCsA-301-SLT
Sponsor: BREATH Therapeutics Inc.
New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons

Principal investigator: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow Device plus Standard of Care versus Standard of Care Alone in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation. Protocol No: BT-LCsA-302-DLT
Sponsor: BREATH Therapeutics Inc.
New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons

Principal investigator: A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow Device plus Standard of Care in the Treatment of Bronchiolitis Obliterans Syndrome in Patients post Single or Double Lung Transplantation.  Protocol No: BT-LCsA-303-FU (BOSTON-3)
Sponsor: BREATH Therapeutics Inc. 
New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons

Principal investigator: Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts (CAG-00324R2).
Sponsor: Center for Medicare and Medicaid Services and Therakos
New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons

Selected Publications

  • A.M. Layton, H.F. Armstrong, H.P. Kim, K.S. Meza, F. D’Ovidio, S.M. Arcasoy. Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation. Respir Med 2017; 126: 59-67.
  • J.M. Diamond, S. Arcasoy, C.C. Kennedy, M. Eberlein, J.P. Singer, G.M. Patterson, J.D. Edelman, G. Dhillon, T. Pena, S.M. Kawut, J.C. Lee, R. Girgis, J. Dark, G. Thabut. Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: Epidemiology, risk factors, and outcomes-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017 Oct;36(10):1104-1113.
  • L.J. Benvenuto, D.R. Anderson, H.P. Kim, J.L. Hook, L. Shah, H.Y. Robbins, F. D’Ovidio, M. Bacchetta, J.R. Sonett, S.M. Arcasoy. Geographic disparities in donor lung supply and lung transplant waitlist outcomes: A Cohort Study. Am J Transplant; 2018; 18:1471-80
  • L.J. Benvenuto, M.R. Anderson, S.M. Arcasoy.  New frontiers in immunosuppression. J Thorac Dis 2018;10(5):3141-55. 
  • M. Aversa, L. Benvenuto, H. Kim, L. Shah, H. Robbins, B.P. Stanifer, F. D'Ovidio, E.R. Vasilescu, J. Sonett, S.M. Arcasoy. Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates. Ann Transplant 2019 Jun 28;24:383-392. 
  • D. Rudym, L. Benvenuto, J. Costa, M. Aversa, H. Robbins, L. Shah, H. Kim, B.P. Stanifer, J. Sonett, F. D’Ovidio, S.M. Arcasoy. What Awaits on the Other Side: Post-Lung Transplant Morbidity and Mortality After Pre-Transplant Hospitalization. Ann Transplant 2020;25:e922641. 
  • M. Aversa, L. Benvenuto, M. Anderson, L. Shah, H. Robbins, M. Pereira, J. Scheffert, M. Carroll, J. Hum, M. Nolan, G. Reilly, P. Lemaitre, B.P. Stanifer, F. D’Ovidio, J. Sonett, S. Arcasoy. Covid-19 in lung transplant recipients: A single center case series from New York City. Am J Transplant 2020; 20:3072-80.